Amol Akhade, Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics, shared a post on LinkedIn:
“Much awaited data of Nivo plus ipi vs Nivo alone in metastatic CRC with high MSI from Checkmate 8HW. Combination better than single agent nivo. But with more toxicity. Should we give single agent or Double agent?”
